Trump GLP-1 update teases blockbuster annual sales for Lilly from Medicare program: analyst

As part of the MFN drug pricing deal the Trump administration signed with obesity giants Eli Lilly and Novo Nordisk, Medicare recently launched a “bridge” model, offering weight loss drugs to eligible seniors at $50 per month. Now, we know the initial uptake from the program.